In: PATENT NEWS
The Maryland law was approved last year. It enabled Maryland’s attorney general to sue makers of off-patent or generic drugs that make an “unconscionable” price increase. That was described as an excessive increase, unjustified by the cost of producing or distributing the drug. Thacker wrote that the …
In: TRADEMARK NEWS
Is your trademark a word mark, a device mark or both? International Law Office Full coverage
In: PATENT NEWS
Tech companies will be closely monitoring the results of BlackBerry’s patent infringement lawsuits against Facebook and Snapchat, which could have a lasting impact on the tech sector and beyond, an Ottawa legal researcher says.
In: PATENT NEWS
ALEXANDRIA, Va., April 13, 2018 /PRNewswire/ — Xsensus, LLP announced today the formation of a new IP law firm, founded by seasoned patent attorneys with a long history of serving a broad spectrum of advanced technology companies. This new firm is innovative and streamlined, designed to …
In: PATENT NEWS
New Hampshire Court: First Amendment Says You Can Call A Patent Troll A Patent Troll Techdirt Full coverage
In: PATENT NEWS
The court ruled [PDF] that the phrase “patent troll” and other rhetorical characterizations are not the type of factual statements that can be the basis of a defamation claim. While this is a fairly routine application of defamation law and the First Amendment, it is an important reminder that patent... Continue reading
In: PATENT NEWS
ANNAPOLIS, Md. (AP) — A federal appeals court has struck down Maryland’s first-in-the-nation law against pharmaceutical price gouging. A divided three-judge … It enabled Maryland’s attorney general to sue makers of off-patent or generic drugs that make an “unconscionable” price increase. That was …
In: PATENT NEWS
Greene’s Energy Group LLC, the U.S. Supreme Court will soon decide whether the U.S. Patent and Trademark Office’s inter partes review procedure is constitutional. IPRs are administrative procedures that review a patent’s validity. The administrative law body responsible for administering these …
In: PATENT NEWS
Frosh’s office could not immediately be reached for comment. The law required health officials share with the attorney general’s office price information about generic drugs — that is, those not subject to a patent. If the state’s lawyers could show that prices were being raised too steeply, they could step... Continue reading
In: TRADEMARK NEWS
Fed Circ. Won’t Rethink ‘Scandalous’ Trademark Ruling Law360 Full coverage
Designed by Industrial Action
Copyright © 2024 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION